Screener
Trevi Therapeutics, Inc. TRVI Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206390
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Other income (expense), net | 4 | (6) |
| Total other income, net | 1,700 | 1,119 |
| Loss before income taxes | (13,212) | (10,351) |
| Income tax benefit | (20) | (11) |
| Net loss | $(13,192) | $(10,340) |
| Basic and diluted net loss per common share outstanding | $(0.09) | $(0.09) |
| Weighted average common shares used in net loss per share attributable to common stockholders, basic and diluted | 145,592,901 | 117,610,750 |
| Net loss | $(13,192) | $(10,340) |
Item 1. Condensed Consolidated Financial Statements.
FAQ
- What is Trevi Therapeutics, Inc.'s income tax?
- Trevi Therapeutics, Inc. (TRVI) reported income tax of -$20K in Q1 2026.
- How has Trevi Therapeutics, Inc.'s income tax changed year-over-year?
- Trevi Therapeutics, Inc.'s income tax decreased by 81.8% year-over-year, from -$11K to -$20K.
- What is the long-term trend for Trevi Therapeutics, Inc.'s income tax?
- Over 2 years (2021 to 2025), Trevi Therapeutics, Inc.'s income tax has grown at a 73.2% compound annual growth rate (CAGR), from -$21K to -$63K.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.
Ask your AI about Trevi Therapeutics, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude